• 18 June 2017

    J&J completes Actelion acquisition for $30bn

    Johnson & Johnson (J&J) has completed the acquisition of Actelion Pharmaceuticals for approximately $30bn in an all-cash transaction through its Swiss subsidiary Janssen Holding.